Compass Therapeutics, Inc. Common Stock
CMPX Real Time Price USDRecent trades of CMPX by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by CMPX's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
CMPX Revenue by Segment or Geography
No Revenue by Segment data for this ticker
No Revenue by Geography data for this ticker
New patents grants
-
Patent Title: Multispecific binding constructs against checkpoint molecules and uses thereof Apr. 30, 2024
-
Patent Title: Cd137 antibodies and tumor antigen-targeting antibodies and uses thereof Dec. 26, 2023
-
Patent Title: Agonist antibodies that bind human cd137 and uses thereof Sep. 12, 2023
-
Patent Title: Cd137 antibodies and pd-1 antagonists and uses thereof Aug. 08, 2023
-
Patent Title: Multispecific binding constructs against checkpoint molecules and uses thereof Jun. 29, 2021
-
Patent Title: Agonist antibodies that bind human cd137 and uses thereof Jul. 21, 2020
-
Patent Title: Agonist antibodies that bind human cd137 and uses thereof Oct. 08, 2019
-
Patent Title: Agonist antibodies that bind human cd137 and uses thereof Jul. 16, 2019
-
Patent Title: Agonist antibodies that bind human cd137 and uses thereof May. 07, 2019
-
Patent Title: Agonist antibodies that bind human cd137 and uses thereof May. 07, 2019
-
Patent Title: Agonist antibodies that bind human cd137 and uses thereof May. 07, 2019
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to CMPX
Number of mentions of CMPX in WallStreetBets Daily Discussion
Recent picks made for CMPX stock on CNBC
ETFs with the largest estimated holdings in CMPX
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view CMPX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.